Moreover, the activation of MAO-A also suppresses the expression of the mitochondrial function regulator PGC-1α, exacerbating mitochondrial dysfunction, thereby promoting the phenotypic changes of ECs towards atherosclerosis and the progression of atherosclerotic disease (Li et al., 2021). The gene discussed is PPARGC1A; the disease is atherosclerosis.